News & Articles

Vascular Specialty Center First to Enroll into National Clinical Trial For Severe PVD

Baton Rouge, LA - Vascular Specialty Center physicians on December 4th, 2006 enrolled the nation’s first two patients into the PROOF trial for critical limb ischemia.  Sponsored by Foxhollow, Inc., the PROOF (Plaque RemOval versus Open Bypass Surgery For Critical Limb Ischemia) Trial is a randomized comparison of the nonsurgical, endovascular athrectomy device (Silverhawk) vs. traditional surgical bypass in treating those at risk for amputation due to severe peripheral vascular disease.  Performed by Dr. Albert D. Sam II, study principle investigator, both procedures were technically successful and the patients were both discharged to home within 24 hours. 

“We are excited with this opportunity to participate in the PROOF trial and to help determine the effectiveness of new endovascular treatments in those with peripheral vascular disease”, says Wendy Frieberger RN BSN CCRC, Vascular Specialty Center Director of Clinical Research .

About Vascular Specialty Center, PMC

Vascular Specialty Center in the largest single specialty vascular and endovascular surgical practice in Louisiana with headquarters in Baton Rouge, LA.  Its subsidiaries include Vascular Specialty Laboratory (VSL) and Total Vein Care of Louisiana TM  (TVC).  VSL serves as the largest vascular laboratory in the state and serves the entire Gulf Coast region performing more than 12,000 non-invasive studies yearly.  TVC is the leading freestanding gulf coast clinic dedicated to the complete medical, surgical and cosmetic care of problematic veins performing more minimally invasive, endoluminal vein ablations than any center in the Southeastern United States.   

www.brvsc.com
www.TotalVeinCareLouisiana.com